Belarus vs Jamaica: HIV/AIDS deaths averted by antiretroviral therapy
Belarus
1,203 deaths
in 2022
Jamaica
1,044 deaths
in 2022
Belarus rank
71st
Jamaica rank
72nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belarus
- Jamaica
How they compare
Belarus currently reports 1,203 deaths against 1,044 deaths in Jamaica, a difference of 159 deaths.
That makes Belarus's figure about 1.2 times Jamaica's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Jamaica ahead.
Belarus ranks 71st and Jamaica ranks 72nd of 157 countries.
Across the 4 decades both report, Belarus averaged higher in 1 and Jamaica in 2.
Head to head by decade
| Decade | Belarus | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 70.2 deaths | 310 deaths | 239.8 deaths | Jamaica |
| 2010s | 703.4 deaths | 1,136 deaths | 433.1 deaths | Jamaica |
| 2020s | 1,184 deaths | 1,127 deaths | 57 deaths | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belarus or Jamaica?
- Belarus, at 1,203 deaths against 1,044 deaths in Jamaica as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belarus and Jamaica?
- 159 deaths, with Belarus ahead.
- How many years of comparable data are there for Belarus and Jamaica?
- 33 years are reported by both, from 1990 to 2022.
- How do Belarus and Jamaica rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belarus ranks 71st and Jamaica ranks 72nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.